DEFINING AND MEASURING THE COSTS OF THE HIV EPIDEMIC TO BUSINESS FIRMS
Saved in:
FARNHAM, P.G., DEFINING AND MEASURING THE COSTS OF THE HIV EPIDEMIC TO BUSINESS FIRMS. PUBLIC HEALTH REPORTS, Vol. 109, no. 3 (1994), p. 311-318.
Ref.
38340
Location:
SIIS R.945
Palabras clave:
Coste, Gasto social, Sida, Tratamiento
Coste, Gasto social, Sida, Tratamiento
Similar Items: DEFINING AND MEASURING THE COSTS OF THE HIV EPIDEMIC TO BUSINESS FIRMS
- COUNSELING AND TESTING FOR HIV PREVENTION: COSTS, EFFECTS, AND COST-EFFECTIVENESS OF MORE RAPID SCREENING TESTS
- COST EFFECTIVENESS OF "HAART". THE SOCIAL CONSEQUENCES FOR HIV / AIDS CARE
- HIV INFECTION TREATMENT COSTS UNDER MEDICAID IN MICHIGAN
- ABSENTEEISM AND BUSINESS COSTS: DOES SUBSTANCE ABUSE MATTER?
- EFFECT OF INCENTIVES FOR MEDICATION ADHERENCE ON HEALTH CARE USE AND COSTS IN METHADONE PATIENTS WITH HIV
- DEFINING THE CHALLENGES OF PROVIDING LONG-TERM CARE: THE CASE OF THE NURSING HOME INDUSTRY'S RESPONSE TO THE AIDS EPIDEMIC